| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Trading | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 28/Apr/1947 | | Canada | | |
|
|
| Exchange Filing Office |
| Location |
| Vancouver Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Pharmaceutical Manufacturer and Distributor
| BioSyent Inc. is a publicly traded specialty pharmaceutical company whose
wholly owned subsidiary, BioSyent Pharma Inc., sources, acquires or in-licences pharmaceutical products and markets these products in Canada. Wholly owned BioSyent subsidiary Hedley Technologies Ltd. operates the company's legacy business marketing bio and health friendly non-chemical insecticides. BioSyent common shares are listed for trading on the TSX Venture Exchange (TSXV) under the symbol RX.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| RX | BioSyent Inc. | TSX Venture | TRADING |
|
|
| Name History | From | To |
| BioSyent Inc. | 13/Jun/2006 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
